If GLP-1 helps communicate fullness and reduce appetite, GIP appears to play a larger role in how the body processes nutrients, responds to insulin, and manages energy after eating
Because the first dose is typically a low loading dose (0.25 mg), the body is being gently introduced to the medication to minimize stress on the digestive system
However, complete discontinuation typically results in weight regain, making CagriSema a long-term commitment requiring indefinite maintenance dosing
Wang Y, Tao A, Vaeth M, Feske S
Monitoring and bloodwork Regular monitoring during semaglutide therapy is standard practice regardless of the formulation
Understanding how tirzepatide regulates blood sugar through glucose-dependent mechanisms is essential for both healthcare providers and patients when assessing the medication's safety profile, particularly regarding hypoglycemia risk